Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$8.54B |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$6.22B |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$6.12B |
| 4 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$5.39B |
| 5 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$367M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$335M |
| 3 |
Diageo
DEO
|
+$297M |
| 4 |
Medtronic
MDT
|
+$259M |
| 5 |
GE Aerospace
GE
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.36% |
| 2 | Financials | 10.66% |
| 3 | Healthcare | 9.68% |
| 4 | Consumer Discretionary | 8.35% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3426
Atara Biotherapeutics
ATRA
$72.6M
| $222K | ﹤0.01% |
26,155
-4,299
| -14% | -$64.6K |
|
|
MKFG
3427
DELISTED
Markforged Holding Corporation
MKFG
| $221K | ﹤0.01% |
53,834
-3,394
| -6% | -$18.5K |
|
3428
Fractyl Health
GUTS
$109M
| $219K | ﹤0.01% |
51,402
+17,813
| +53% | +$115K |
|
3429
VirTra
VTSI
$33.1M
| $219K | ﹤0.01% |
+28,501
| New | +$328K |
|
3430
PGIM Ultra Short Bond ETF
PULS
$17.7B
| $219K | ﹤0.01% |
+4,401
| New | +$218K |
|
3431
Lifeway Foods
LWAY
$480M
| $218K | ﹤0.01% |
+17,108
| New | +$311K |
|
3432
PrimeEnergy Resources
PNRG
$298M
| $218K | ﹤0.01% |
2,052
| – | – |
|
3433
CervoMed
CRVO
$23M
| $218K | ﹤0.01% |
+12,722
| New | +$278K |
|
3434
Verastem
VSTM
$528M
| $211K | ﹤0.01% |
70,810
+59,651
| +535% | +$492K |
|
3435
Eos Energy Enterprises
EOSE
$1.14B
| $211K | ﹤0.01% |
166,111
-231,803
| -58% | -$192K |
|
3436
Nuveen Floating Rate Income Fund
JFR
$1.23B
| $210K | ﹤0.01% |
+24,303
| New | +$211K |
|
3437
Mammoth Energy Services
TUSK
$122M
| $210K | ﹤0.01% |
63,981
| – | – |
|
3438
TSMC
TSM
$1.94T
| $206K | ﹤0.01% |
+1,187
| New | +$180K |
|
3439
Empire Petroleum
EP
$101M
| $203K | ﹤0.01% |
39,303
+6,390
| +19% | +$38.4K |
|
3440
iShares Select U.S. REIT ETF
ICF
$2.13B
| $202K | ﹤0.01% |
3,528
-935
| -21% | -$51.8K |
|
3441
Critical Metals Corp
CRML
$754M
| $195K | ﹤0.01% |
+17,306
| New | +$182K |
|
3442
MediciNova
MNOV
$63.5M
| $194K | ﹤0.01% |
+134,793
| New | +$189K |
|
3443
Werewolf Therapeutics
HOWL
$22.4M
| $192K | ﹤0.01% |
+78,842
| New | +$379K |
|
3444
System1
SST
$14.3M
| $185K | ﹤0.01% |
12,169
-4,303
| -26% | -$72.6K |
|
|
GRFS
3445
Grifois
GRFS
$5.55B
| $184K | ﹤0.01% |
+29,242
| New | +$203K |
|
3446
Metagenomi Therapeutics
MGX
$45.6M
| $184K | ﹤0.01% |
45,111
+14,963
| +50% | +$103K |
|
|
RDNW
3447
RideNow Group
RDNW
$256M
| $178K | ﹤0.01% |
+43,467
| New | +$238K |
|
3448
Genelux
GNLX
$127M
| $176K | ﹤0.01% |
90,303
-62,206
| -41% | -$211K |
|
|
SWKH
3449
DELISTED
SWK Holdings
SWKH
| $173K | ﹤0.01% |
12,856
| – | – |
|
3450
HireQuest
HQI
$190M
| $173K | ﹤0.01% |
13,973
| – | – |
|
Similar funds
Charles Schwab's Q2 2024 Portfolio in Review
As of Q2 2024, Charles Schwab held 3,738 positions worth $525B, up 21% from $433B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Charles Schwab deployed $84.3B of net new capital in Q2 2024, opening 263 new positions and adding to 2,391 existing holdings. Its largest new stake was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Texas Instruments, an estimated $367M trimmed.
- Charles Schwab's largest Q2 2024 buy was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
- Charles Schwab added most to Schwab Fundamental US Large Company Index ETF in Q2 2024, an estimated $8.54B increase.
- Charles Schwab's biggest Q2 2024 reduction was Texas Instruments, cutting an estimated $367M.
- Charles Schwab fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $335M.
- Charles Schwab's ten largest holdings make up 21% of its $525B portfolio in Q2 2024.
- Charles Schwab opened 263 new positions and closed 116 in Q2 2024.
- Charles Schwab's portfolio value rose 21% quarter-over-quarter to $525B.
Based on Charles Schwab's 13F filing for Q2 2024, filed 12 Aug 2024.